From initial gastrointestinal protection studies, the research expanded to include wound healing, musculoskeletal repair, neurological effects, cardiovascular applications, and cytoprotection against various toxins [2]
Drug Abuse and Dependence 9.1 Controlled Substance VYVANSE contains lisdexamfetamine, a prodrug of amphetamine, a Schedule II controlled substance
Clinical evidence is evolving, and more research is required to fully establish long-term safety and efficacy
It suggests that there is preferential activation of the c-MET receptors along the tumour invasive front compared with the tumour core
The RAI therapy, while effective, often causes hypothyroidism, and this requires lifelong replacement with thyroid hormones
GLP-1 medications affect receptors in the brain that signal satiety